Evolving Role of BTK Inhibitors in CLL: Sequencing, Combinations, and Novel Agents

Download All
Gain insights on the evolving role of BTK inhibitors for patients with CLL with an on-demand webcast, downloadable slidesets, and a podcast on frequently asked questions in CLL.
Farrukh T. Awan, MD
Nicole Lamanna, MD

Downloadable Slidesets

Download these expert-selected slides on current best practices and standard treatments for the management of CLL/SLL in the first-line and relapsed settings.

Farrukh T. Awan, MD Nicole Lamanna, MD Released: October 5, 2022

Download this short summary slideset of key takeaways from a live webinar on treatment selection for patients with CLL in the frontline and recurrent settings.

Farrukh T. Awan, MD Nicole Lamanna, MD Released: October 10, 2022

On-Demand Webcast

Watch this on-demand webcast from a SOHO satellite symposium on BTK inhibitors for the management of CLL in frontline and the recurrent setting, including discussions on AE management and treatment sequencing.

Farrukh T. Awan, MD Nicole Lamanna, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) ABIM MOC: maximum of 1.0 Medical Knowledge MOC point(s) Released: October 28, 2022 Expired: October 27, 2023

Podcast

In this podcast episode, listen to Farrukh T. Awan, MD, and Nicole Lamanna, MD, answer questions from an audience of healthcare professionals on the evolving role of BTK inhibitors in CLL, including sequencing, combinations, and novel agents.

Farrukh T. Awan, MD Nicole Lamanna, MD Released: November 9, 2022
Provided by Medical Learning Institute, Inc. in partnership with Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This CE activity is supported through an educational grant from
AstraZeneca
BeiGene
Lilly

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings